| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.12T | 4.90T | 4.91T | 4.40T | 3.92T |
| Gross Profit | 618.93B | 544.11B | 531.85B | 384.04B | 430.67B |
| EBITDA | 500.04B | 461.25B | 407.25B | 339.40B | 414.63B |
| Net Income | 171.70B | 107.59B | 90.81B | 37.67B | 141.94B |
Balance Sheet | |||||
| Total Assets | 4.51T | 4.28T | 4.64T | 4.14T | 4.21T |
| Cash, Cash Equivalents and Short-Term Investments | 592.40B | 451.69B | 527.19B | 317.69B | 386.91B |
| Total Debt | 686.00B | 697.29B | 794.66B | 910.47B | 944.31B |
| Total Liabilities | 2.02T | 2.05T | 2.24T | 2.14T | 2.21T |
| Stockholders Equity | 2.20T | 1.98T | 2.14T | 1.75T | 1.76T |
Cash Flow | |||||
| Free Cash Flow | 134.29B | 121.02B | 271.59B | 25.66B | -24.44B |
| Operating Cash Flow | 376.08B | 339.87B | 499.74B | 237.97B | 193.34B |
| Investing Cash Flow | -77.18B | -146.95B | -93.15B | -186.86B | -204.95B |
| Financing Cash Flow | -181.97B | -270.22B | -211.70B | -127.75B | -135.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥531.09B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
72 Outperform | ¥7.72T | 15.56 | 8.97% | 1.38% | 6.56% | 38.17% | |
68 Neutral | ¥5.22T | 11.95 | 6.98% | 2.98% | 5.28% | 12.66% | |
68 Neutral | ¥616.18B | 28.26 | ― | 3.52% | 7.58% | 162.60% | |
66 Neutral | ¥594.33B | 43.48 | 3.35% | 3.18% | 2.15% | -6.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥1.79T | 9.32 | 8.34% | 2.03% | 4.53% | 65.12% |